Research Article

NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer

Figure 8

Mutation status of NCOA4 in TCGA tumors. (a) The alteration frequency with mutation type. (b) The mutation site of NCOA4. (c) Analysis of the relationship between mutation status and OS, DSS, disease-specific survival (DFS), and progression-free survival (PFS) of CRC, analyzed by cBioPortal tool. (d) Promoter methylation level of NCOA4 in pan-cancer. (ns: ; ; ; ; ).
(a)
(b)
(c)
(d)